Carregant...
Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
Insulin glargine is processed in vivo into soluble 21(A)-Gly-human insulin (M1), the principal moiety responsible for metabolic effects, and subsequently into M2. This sub-study compared metabolism and metabolite pharmacokinetic (PK) profiles of investigational new insulin glargine U300 (Gla-300) wi...
Guardat en:
| Publicat a: | Diabetes Obes Metab |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Blackwell Publishing Ltd
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4237557/ https://ncbi.nlm.nih.gov/pubmed/24571126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12283 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|